U.S. Capital Wealth Advisors’s Idexx Laboratories IDXX Stock Holding History

U.S. Capital Wealth Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-196	Closed	-$80K	–	1047
2022 Q4	$80K	Buy	+196	New	+$76.1K	﹤0.01%	769
2022 Q2	–	Sell	-1,171	Closed	-$641K	–	700
2022 Q1	$641K	Sell	1,171 -10	-0.8%	-$5.26K	0.02%	464
2021 Q4	$778K	Buy	1,181 +4	+0.3%	+$2.51K	0.03%	441
2021 Q3	$732K	Buy	+1,177	New	+$791K	0.03%	443

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

U.S. Capital Wealth Advisors's IDXX Position: Q1 2023 in Review

U.S. Capital Wealth Advisors sold out of Idexx Laboratories (IDXX) in Q1 2023, closing a stake of 196 shares — an estimated $80K sold.

U.S. Capital Wealth Advisors first reported a position in IDXX in Q3 2021 and held it in 4 quarters. The position peaked at $778K in Q4 2021. 1,055 funds tracked by Wall St. Rank hold IDXX as of Q1 2023.

U.S. Capital Wealth Advisors reported no remaining Idexx Laboratories position as of Q1 2023 after selling out during the quarter.
U.S. Capital Wealth Advisors sold 196 Idexx Laboratories shares in Q1 2023, an estimated $80K.
U.S. Capital Wealth Advisors first reported a position in Idexx Laboratories in Q3 2021 and held it in 4 quarters.
U.S. Capital Wealth Advisors's Idexx Laboratories position peaked at $778K in Q4 2021.
1,055 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2023.

Based on U.S. Capital Wealth Advisors's 13F filing for Q1 2023, filed 11 May 2023.